As the scientific community looks deeper into these potential links and the reasons behind them, medical professionals reiterate the importance of seeking tailored medical advice.
The study, led by Dr Kamakshi Lakshminarayan from the University of Minnesota School of Public Health, examined 5,712 participants with an average age of 75.
“In summary, we found a positive but non-significant association between the current use of proton pump inhibitors (PPI)s and the risk of dementia over a median 5.5 years of follow-up.”
Stressing on the problem since PPI’s have become available easily over-the-counter, Dr Jayadevan says that many people pop them like candy — without medical advice.
Dr Kamakshi Lakshminarayan says that in light of these findings and concerns, she urges patients not to make abrupt changes in their medication routine.